Peripheral insulin resistance has been implicated in stimulating tau phosphorylation, increasing amyloid-beta toxicity, exacerbating oxidative stress, and compromising synaptic integrity, ultimately contributing to cognitive decline (Kellar and Craft, 2020). The gene discussed is MAPT; the disease is Insulin resistance.